Fairmount Partners Advises Infusion in Their Acquisition by Avanade

SEATTLE, WA – February 28, 2017 – Avanade announced it has acquired Infusion, a global software engineering, design and digital strategy firm that delivers digital business transformation for the enterprise with strong Microsoft technology expertise. The acquisition expands Avanade’s capabilities to deliver digital transformation services and reinforces its position as the leading digital innovator in […]

Fairmount Assists Charles River Labs to Divest QS Pharma to Quotient Clinical

Nottingham, UK – February 14, 2017 – Quotient Clinical (“Quotient”), the early phase drug development services provider, today announces that it has acquired QS Pharma, the contract development and manufacturing organisation (CDMO), based in Philadelphia, from Charles River Laboratories International, Inc.  (NYSE: CRL).   Charles River acquired QS Pharma as part of its 2016 acquisition of […]